Wells Fargo cuts target for Sabra Health Care REIT stock to USD 21.00
Published on 10/20/2026 at 20:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and reporting date
- Wells Fargo lowered its target from USD 23.00 to USD 21.00 on October 19, 2026.
- Second-quarter 2026 revenue reached USD 230.11 million, up 24.70 percent year over year.
- Sabra Health Care REIT stock costs EUR 17.26 at Lang & Schwarz on October 20, 2026 at 8:00 p.m. CEST.
- Sabra plans to release third-quarter 2026 results on November 2, 2026.
Wells Fargo lowered its target for Sabra Health Care REIT from USD 23.00 to USD 21.00 on October 19, 2026, while maintaining an Overweight rating, according to MarketBeat. Sabra Health Care REIT stock was trading at EUR 17.26 at Lang & Schwarz on October 20, 2026 at 8:00 p.m. CEST.
Revenue rose in the second quarter
Sabra reported USD 230.11 million of revenue for the second quarter of 2026, up 24.70 percent from the same quarter a year earlier. Net income was a loss of USD 25.25 million, compared with net income of USD 40.81 million in the first quarter of 2026. Diluted earnings per share were negative USD 0.10. The figures are also reported by GreekSoup from Sabra's filings.
Stock remains inside its yearly range
The Nasdaq-listed REIT had a market capitalization of USD 5.0 billion and a price-to-earnings ratio of 73.86 as of October 20, 2026 at 2:03 p.m. ET. Its 52-week range was USD 17.17 to USD 22.77. The same quote showed Sabra at USD 19.39, with a volume of 850,165 shares.
November brings the next report
Business Wire reported on October 19, 2026 that Sabra will release third-quarter 2026 results on November 2, 2026, after the close of trading. The company scheduled its conference call for November 3, 2026 at 10:00 a.m. Pacific Time. A separate MarketBeat calendar estimates the report for November 4, 2026 and lists consensus revenue of USD 235.44 million. The company release is the earlier dated confirmation.
Comparison with peers
Sabra Health Care REIT: price-to-earnings ratio 73.86, market capitalization USD 5.0 billion, dividend yield 6.20 percent as of October 20, 2026. Welltower (NYSE, USD): plus 1.62 percent, price-to-earnings ratio 125.65, market capitalization USD 171.0 billion as of October 20, 2026. Healthpeak Properties (NYSE, USD): plus 2.15 percent, price-to-earnings ratio 53.73, market capitalization USD 13.0 billion as of October 20, 2026.
Price and investor calendar
Sabra combines a 6.20 percent dividend yield with a 73.86 price-to-earnings ratio and a second-quarter revenue increase of 24.70 percent. The next company milestone is the November 2, 2026 results release, while the latest analyst action points to a USD 21.00 Wells Fargo target.
Sabra Health Care REIT stock was trading at EUR 17.26 at Lang & Schwarz on October 20, 2026 at 8:00 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Sabra Health Care REIT stock.
Sabra Health Care REIT at a glance
- Company: Sabra Health Care REIT, Inc.
- ISIN: US78573L1061
- Ticker: SBRA
- Primary exchange: Nasdaq
- Price Lang & Schwarz (as of October 20, 2026, 8:00 p.m. CEST): EUR 17.26
- Market capitalization: USD 5.0 billion (as of October 20, 2026)
- 52-week range: USD 17.17-22.77 (as of October 20, 2026)
- Sector / Industry: Real Estate / Healthcare Facilities REIT
Market context: Market report Nasdaq Composite.
